BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,714,780 | -16.5% | 151,425 | +0.8% | 0.02% | -10.5% |
| Q2 2023 | $6,842,656 | -53.6% | 150,190 | -58.7% | 0.02% | -55.8% |
| Q1 2023 | $14,753,092 | +79.4% | 363,735 | +125.5% | 0.04% | +65.4% |
| Q4 2022 | $8,222,837 | -12.7% | 161,327 | -7.8% | 0.03% | -10.3% |
| Q3 2022 | $9,424,000 | -24.1% | 174,969 | -9.5% | 0.03% | -23.7% |
| Q2 2022 | $12,422,000 | -3.3% | 193,397 | +16.8% | 0.04% | +18.8% |
| Q1 2022 | $12,841,000 | +38.1% | 165,600 | +52.9% | 0.03% | +33.3% |
| Q4 2021 | $9,296,000 | -34.7% | 108,300 | -38.8% | 0.02% | -42.9% |
| Q3 2021 | $14,225,000 | -13.3% | 176,856 | -13.2% | 0.04% | -10.6% |
| Q2 2021 | $16,410,000 | +42.2% | 203,856 | +49.0% | 0.05% | +30.6% |
| Q1 2021 | $11,542,000 | -31.4% | 136,856 | -34.7% | 0.04% | -29.4% |
| Q4 2020 | $16,823,000 | -15.4% | 209,656 | -15.2% | 0.05% | -27.1% |
| Q3 2020 | $19,892,000 | +13.1% | 247,356 | +21.0% | 0.07% | +7.7% |
| Q2 2020 | $17,595,000 | -19.7% | 204,356 | -24.3% | 0.06% | -32.3% |
| Q1 2020 | $21,918,000 | -33.7% | 269,956 | -31.8% | 0.10% | -20.7% |
| Q4 2019 | $33,076,000 | +3.1% | 395,556 | +7.9% | 0.12% | -11.0% |
| Q3 2019 | $32,071,000 | -3.3% | 366,656 | -9.4% | 0.14% | -4.9% |
| Q2 2019 | $33,158,000 | +36.7% | 404,856 | +35.7% | 0.14% | +31.2% |
| Q1 2019 | $24,259,000 | +94.9% | 298,356 | +57.7% | 0.11% | +60.3% |
| Q4 2018 | $12,450,000 | -25.5% | 189,148 | -12.7% | 0.07% | -11.7% |
| Q3 2018 | $16,709,000 | +4.4% | 216,748 | +0.0% | 0.08% | +5.5% |
| Q2 2018 | $16,001,000 | +8.5% | 216,699 | -4.5% | 0.07% | +7.4% |
| Q1 2018 | $14,751,000 | -9.1% | 226,799 | -9.7% | 0.07% | -8.1% |
| Q4 2017 | $16,234,000 | +18.2% | 251,143 | +14.7% | 0.07% | +17.5% |
| Q3 2017 | $13,739,000 | -11.3% | 218,943 | -14.4% | 0.06% | -12.5% |
| Q2 2017 | $15,483,000 | -2.8% | 255,743 | -16.7% | 0.07% | -8.9% |
| Q1 2017 | $15,925,000 | +29.9% | 307,078 | +11.1% | 0.08% | +33.9% |
| Q4 2016 | $12,259,000 | -27.2% | 276,478 | -21.8% | 0.06% | -34.4% |
| Q3 2016 | $16,831,000 | +21.7% | 353,600 | +15.6% | 0.09% | +9.8% |
| Q2 2016 | $13,833,000 | +89.3% | 305,900 | +72.0% | 0.08% | +54.7% |
| Q1 2016 | $7,308,000 | -10.1% | 177,900 | -16.5% | 0.05% | -7.0% |
| Q4 2015 | $8,129,000 | +514.4% | 213,100 | +428.8% | 0.06% | +418.2% |
| Q3 2015 | $1,323,000 | -84.3% | 40,300 | -66.5% | 0.01% | -84.7% |
| Q2 2015 | $8,420,000 | +2.1% | 120,400 | 0.0% | 0.07% | +12.5% |
| Q1 2015 | $8,247,000 | -31.2% | 120,400 | -26.4% | 0.06% | -34.7% |
| Q4 2014 | $11,990,000 | -35.0% | 163,600 | -36.3% | 0.10% | -34.7% |
| Q3 2014 | $18,438,000 | -23.0% | 256,900 | -22.5% | 0.15% | -24.6% |
| Q2 2014 | $23,953,000 | +61.0% | 331,300 | +63.8% | 0.20% | +50.8% |
| Q1 2014 | $14,878,000 | -0.6% | 202,200 | -6.0% | 0.13% | -7.0% |
| Q4 2013 | $14,967,000 | -34.0% | 215,200 | -37.6% | 0.14% | -41.1% |
| Q3 2013 | $22,663,000 | -4.0% | 345,000 | +1.2% | 0.24% | -14.8% |
| Q2 2013 | $23,607,000 | – | 340,800 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |